RecruitingNCT07587866

Panuri Performance Study

Evaluation of the Performance of Panuri - Test for Detection of Pancreatic Ductal Adenocarcinoma

Sponsor

Urteste S.A

Enrollment

1,100 participants

Start Date

Jun 10, 2026

Study Type

OBSERVATIONAL

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC)

Summary

The main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases. The study aims to characterize the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma in patients with symptoms supporting a clinical suspicion of pancreatic cancer The Panuri test is intended for professional laboratory use for diagnostic purposes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Panuri test for people with pancreatic ductal adenocarcinoma (pdac). The study is currently recruiting participants at 32 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPanuri test

In vitro diagnostic assay designed to detect, in human urine samples pancreatic ductal adenocarcinoma

Locations(32)

Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház

Békéscsaba, Hungary

Pankreász Betegségek Intézete Semmelweis Egyetem

Budapest, Hungary

Bács-Kiskun Vármegyei Oktatókórház

Kecskemét, Hungary

Csőszi Endoszkópos Kft.

Kecskemét, Hungary

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ Dr. Bugyi István Szentesi Multidiszciplináris Centrum

Szentes, Hungary

Gastroenterologia ed Endoscopia digestiva Ospedale "Morgagni - Pierantoni" di Forlì

Forlì, Italy

Pancreas Translational and Clinical Center IRCCS Ospedale San Raffaele

Milan, Italy

Unità di Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Istituto Europeo di Oncologia (IEO)

Milan, Italy

SC Chirurgia Generale 1 Fondazione IRCCS Policlinico "San Matteo"

Pavia, Italy

UOC Gastroenterologia Azienda Ospedaliero Universitaria Pisana

Pisa, Italy

Unità Operativa Complessa di Endoscopia Digestiva Chirurgica Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, Italy

Unità Operativa di Chirurgia Pancreatica IRCCS Istituto Clinico Humanitas

Rozzano, Italy

Niepubliczny Zakład Opieki Zdrowotnej "Diagmed" J.Bajorek, N.Kopeć Spółka Jawna

Dąbrowa Tarnowska, Poland

SPZOZ Uniwersyteckie Centrum Kliniczne Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej

Gdansk, Poland

Przychodnia KOPERNIKA Sp. z o.o.

Grudziądz, Poland

Ośrodek Badań Klinicznych BD Research Sp. z o.o.

Iława, Poland

OŚRODEK MEDYCZNY "OSTEOMED" S.C. Mirosław Szlachcic, Ewa Szlachcic

Krakow, Poland

Comarch Healthcare S.A. Centrum Medyczne iMed24

Krakow, Poland

Salve Medica Sp. z o.o.

Lodz, Poland

Zanamed Medical Clinic Sp. z o.o.

Lublin, Poland

Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp. z o.o.

Malbork, Poland

Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o.

Pleszew, Poland

Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie

Poznan, Poland

Uniwersytecki Szpital Kliniczny nr 1 im. Prof. Tadeusza Sokołowskiego PUM w Szczecinie

Szczecin, Poland

Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka Sp. z. o.o.

Słupsk, Poland

Metabolica Sp. z o.o.

Tarnów, Poland

Onkomedica Sp. z o.o.

Warsaw, Poland

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji

Warsaw, Poland

Wielospecjalistyczny Szpital Medicover

Warsaw, Poland

Military Institute of Medicine - National Research Institute

Warsaw, Poland

Centrum Medyczne K2J2

Wołomin, Poland

4 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej we Wrocławiu

Wroclaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07587866

Related Trials

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT0749144520 locations

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT0756215225 locations

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

NCT0764455918 locations

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT077022926 locations

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT073495379 locations